Syntal Capital Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Syntal Capital Partners’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,667	Closed	-$402K	–	266
2019 Q1	$402K	Buy	+2,667	New	+$384K	0.18%	84
2018 Q4	–	Sell	-4,635	Closed	-$734K	–	107
2018 Q3	$734K	Buy	+4,635	New	+$701K	0.26%	71
2018 Q1	–	Sell	-8,162	Closed	-$1.02M	–	155
2017 Q4	$1.02M	Buy	+8,162	New	+$1.01M	0.31%	66

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Syntal Capital Partners's FBT Position: Q2 2019 in Review

Syntal Capital Partners sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2019, closing a stake of 2,667 shares — an estimated $402K sold.

Syntal Capital Partners first reported a position in FBT in Q4 2017 and held it in 3 quarters. The position peaked at $1.02M in Q4 2017. 222 funds tracked by Wall St. Rank hold FBT as of Q2 2019.

Syntal Capital Partners reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2019 after selling out during the quarter.
Syntal Capital Partners sold 2,667 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2019, an estimated $402K.
Syntal Capital Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2017 and held it in 3 quarters.
Syntal Capital Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.02M in Q4 2017.
222 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2019.

Based on Syntal Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.